HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.

AbstractPURPOSE OF REVIEW:
Apolipoprotein C-III (ApoC-III) is a widely known player in triglyceride metabolism, and it has been recently recognized as a polyhedric factor which may regulate several pathways beyond lipid metabolism by influencing cardiovascular, metabolic, and neurological disease risk. This review summarizes the different functions of ApoC-III and underlines the recent findings related to its multifaceted pathophysiological role.
RECENT FINDINGS:
The role of ApoC-III has been implicated in HDL metabolism and in the development of atherosclerosis, inflammation, and ER stress in endothelial cells. ApoC-III has been recently considered an important player in insulin resistance mechanisms, lipodystrophy, diabetic dyslipidemia, and postprandial hypertriglyceridemia (PPT). The emerging evidence of the involvement of ApoC-III in the in the pathogenesis of Alzheimer's disease open the way to further study if modification of ApoC-III level slows disease progression. Furthermore, ApoC-III is clearly linked to cardiovascular disease (CVD) risk, and progression of coronary artery disease (CAD) as well as the calcification of aortic valve and recent clinical trials has pointed out the inhibition of ApoC-III as a promising approach to manage hypertriglyceridemia and prevent CVD. Several evidences highlight the role of ApoC-III not only in triglyceride metabolism but also in several cardio-metabolic pathways. Results from recent clinical trials underline that the inhibition of ApoC-III is a promising therapeutical strategy for the management of severe hypertriglyceridemia and in CVD prevention.
AuthorsAntonina Giammanco, Rossella Spina, Angelo B Cefalù, Maurizio Averna
JournalCurrent atherosclerosis reports (Curr Atheroscler Rep) Vol. 25 Issue 3 Pg. 67-76 (03 2023) ISSN: 1534-6242 [Electronic] United States
PMID36689070 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
Copyright© 2023. The Author(s).
Chemical References
  • Apolipoprotein C-III
  • Triglycerides
  • APOC3 protein, human
Topics
  • Humans
  • Apolipoprotein C-III (metabolism)
  • Coronary Artery Disease (complications)
  • Endothelial Cells (metabolism)
  • Hypertriglyceridemia (metabolism)
  • Lipid Metabolism
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: